Chicago, IL – Eng IndX, part of the global Engineering Group, is leading the execution of a national pharmaceutical traceability pilot in Libya. The initiative is designed to validate country-scale serialization and track-and-trace infrastructure under real operating conditions before the nationwide mandate and commercial rollout.
The pilot is operated by the Libya Trade Network, affiliated with Libya’s Ministry of Economy, and is built with IndX’s Movilitas.Cloud platform as the core traceability system. Boehringer Ingelheim is one of the Marketing Authorization Holders (MAH) for the pilot and GS1 Libya is involved, given the fact that GS1 standards are being used.
Rather than enforcing regulation upfront, Libya has taken an execution-led approach: first prove that serialization, transaction traceability, and regulatory oversight can function reliably across a real national supply chain - then scale.
From Regulation to Operational Proof
Pharmaceutica traceability programs often fail not because regulations are unclear, but because systems break down when exposed to real-world complexity. Fragmented supply chains, inconsistent connectivity, and uneven stakeholder readiness quickly expose the gap between policy intent and execution.
Libya’s pilot directly addresses this challenge. The program is focused on validating:
- End-to-end product serialization and aggregation aligned with GS1 standards
- EPCIS-based transaction tracking across changes in ownership
- Secure onboarding of importers, distributors, and dispensers
- Practical regulatory visibility that does not disrupt commercial operations
The pilot is conducted on a live, production-grade cloud platform from IndX using real products and real supply-chain participants - not simulations or controlled demonstrations.
IndX’s Role: Execution Across the Digital Thread
As the execution partner, IndX is responsible for ensuring the traceability system functions end to end from physical product movement to trusted digital records accessible by regulators.
IndX’s scope includes:
- System integration across manufacturers, importers, distributors, and dispensers
- Design and execution of Transaction Information (TI) and Transaction Statement (TS) workflows
- EPCIS exchange enablement between authorized trading partners
- Verification and trace-response logic across ownership changes
- Alignment between operational processes and regulatory oversight
IndX was chosen due to its global expertise in pharmaceutical traceability (19 out of top 20pharma companies work with IndX), its advisory experience with organizations like UNICEF on track & trace, and their recent successful delivery of a nationwide traceability system in the UAE.
“Serialization initiatives succeed or fail at the execution layer. This pilot is about proving that traceability can operate reliably across an entire national supply chain -not in theory, but in practice. IndX’s execution-led approach is critical to making these programs scalable and sustainable at a nationwide level, as IndX did recently in the UAE.” - Marc Blekkink,Managing Director, Movilitas.Cloud
Traceability Foundation Built for National Scale
The pilot leverages Movilitas.Cloud’s SaaS-based traceability platform, selected for its ability to support both serial-based verification and transaction-based tracing across highly distributed environments. Key capabilities include serialization and aggregation across manufacturing and logistics, mobile scanning, including offline operation, EPCIS exchange, ERP, packaging line & regulatory integration, and support for multi-tenant, country-scale deployments.
A Disciplined Path to National Rollout
Following completion of the pilot, Libya Trade Network will evaluate system performance, stakeholder adoption, and regulatory alignment before determining the next steps for a national deployment.
“Our objective is to secure the pharmaceutical supply chain through systems that function in real conditions. This pilot allows us to validate technology, processes, and stakeholder readiness before any national mandate is introduced. It is a responsible and transparent approach.” - Yahya Ganjour,Chairman Libyan T&T pilot, Libya Trade Network
The proposed national model includes:
- Mandatory participation across the pharmaceutical supply chain
- A sustainable operating framework
- Legal and regulatory enforcement aligned with the digital system
If adopted, the initiative would position Libya among a growing group of countries implementing modern, cloud-based pharmaceutical traceability grounded in operational validation rather than theory.
About IndX
A leader in digital transformation, the Engineering Group is a global software provider, system integrator and trusted partner for technology solutions and services. With annual revenues exceeding $1.7 billion and a team of approximately 14,000 professionals across more than 70 offices worldwide—including the U.S., Mexico, Italy, Belgium, Spain, Germany, Serbia, Brazil and Argentina—the Engineering Group delivers innovative solutions in over 50 countries, focusing on areas where digitalization is driving the greatest impact. IndX is the global division of the Engineering Group specializing in the design, integration and implementation of end-to-end digital transformation solutions across the entire lifecycle and supply chain of industrial products and processes. Through platforms such as Movilitas.Cloud, IndX enables secure, compliant and scalable digital solutions for highly regulated industries and governments, including pharmaceutical supply chain traceability and DSCSA compliance.
Media Contacts
IndX: info@indx.com
